FindTrial
Sign In

Myasthenia Gravis Patient Registry: He'nan Myasthenia Gravis Study Collaboration Group Database

He'nan Myasthenia Gravis Study Collaboration Group Database: the Clinical Characteristics, Response to Treatments and Prognosis of Myasthenia Gravis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100050279
Enrollment
Unknown
Registered
2021-08-25
Start date
2021-09-01
Completion date
Unknown
Last updated
2022-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myasthenia Gravis

Interventions

Surgery group:Thymectomy
Medication group:Medication (hormones and/or immunosuppressants)

Sponsors

The First Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with myasthenia gravis preliminarily diagnosed in our hospital since June 2011.

Exclusion criteria

Exclusion criteria: 1.Excluding a diagnosis of myasthenia gravis after differential diagnosis; 2.Neurological and psychiatric disorders that cannot cooperate with communication and regular follow-ups.

Design outcomes

Primary

MeasureTime frame
Post-Intervention status;—

Secondary

MeasureTime frame
Systemic transformation of ocular myasthenia gravis;Biomarker;—

Countries

China

Contacts

Public ContactZhao Song

The First Affiliated Hospital of Zhengzhou University

songzhao_zzu@163.com+86 371 67967152

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026